SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Marrow Development
Marrow Development Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Marrow Development Spółka z Ograniczoną Odpowiedzialnością
Marrow Development Spółka z Ograniczoną Odpowiedzialnością (KRS 0000748360, NIP 8792705297) is a Polish company, headquartered in Toruń, Kujawsko-Pomorskie voivodeship. MARROW DEVELOPMENT operates in: Construction of residential and non-residential buildings (PKD 41.20.Z). Industry: Building construction. The company has been listed in the National Court Register since September 12, 2018. MARROW DEVELOPMENT's most recently reported net revenue was 0 PLN for 2024.
Historical suspension of activities
Suspension: February 1, 2020 - resumed: May 12, 2020
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
41.20.ZConstruction of residential and non-residential buildings
Other activities
Credibility rating
50.9 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
24
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/8 yrs
Board changes
1
1/8 yrs
PKD changes
0
0/8 yrs
Name changes
0
0/8 yrs
Data from 8 years of registry activity.
Payment reliability score from 2019–2024
Current: D (51/100)
Trend: improving (+6.9 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Standard limit from 2019–2024
Current: 39.67 PLN
Safe: 11.9 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
September 12, 2018
7 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
TORUŃ
KUJAWSKO-POMORSKIE
Primary PKD
41.20.Z
Construction of residential and non-residential buildings
Share capital
5.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
6 years
2019–2024 · profitable: 1/6
Registry entries
19
latest: February 6, 2026
Revenue
0 PLN
2024
Net profit
122.45 PLN
2024
Assets
3.2 K PLN
2024
Equity
N/A
2024
EBITDA
-120 PLN
2024
Valuation
675.92 PLN
Low confidence
Low confidence
Rate business credibility - Marrow Development.
No ratings

News
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.

News
Cieszyn-based Atal S.A. (KRS 0000262397) closed 2025 with revenue of PLN 1.267 bn, net profit of PLN 223.3 m and a 17.6% net margin. The board recommends a PLN 4.50 per share dividend (88% of profit, PLN 194.67 m in total, ~8.6% yield) - lower than the PLN 6.00 paid out of 2024 but still among the highest in the Polish residential-developer sector. Q1 2026 saw handovers double (500 vs 218 YoY); 2026 targets are 2,500-3,000 sold and 3,000-4,000 handed over. Juroszek Holding control: 76.30% of capital.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
MARROW DEVELOPMENT's board has 1 member.
19 historical registry entries for Marrow Development
Change in Section 6 (liquidation, bankruptcy or dissolution)
TO.VII NS-REJ.KRS/887/20/185
Change in Section 6 (liquidation, bankruptcy or dissolution)
TO.VII NS-REJ.KRS/3411/20/341
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Change in Section 1 (basic data)
TO.VII NS-REJ.KRS/3411/20/341/ADE
Trend: improving (-17 days/year)
Score
46/100
Late
3
Average delay
45 days
Max delay
91 days
On-time rate
50%
Latest reporting year
2024
Available years
6
Filing entries
6
Financial statement 2024
Financial statement 2023
Financial statement 2022
Financial statement 2021
Financial statement 2020
Competing companies or those operating in the same market segment as Marrow Development (in Toruń, industry: Building construction).
BYDGOSZCZ· Building construction
Revenue 2024: 200.8 M PLN
BYDGOSZCZ· Building construction
Revenue 2024: 166.2 M PLN
GIEBNIA· Building construction
Revenue 2024: 127.4 M PLN
BIAŁE BŁOTA· Building construction
Revenue 2024: 116.9 M PLN
TORUŃ· Building construction
Revenue 2023: 85.4 M PLN
ŁĄŻYN· Building construction
Revenue 2024: 80.0 M PLN